Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sagent Pharmaceuticals' Clindamycin Injection, USP, an antibiotic which helps treat bacterial infections has received approval by the US FDA.
Subscribe to our email newsletter
Clindamycin treats serious infections caused by susceptible anaerobic bacteria, besides treating infections due to susceptible strains of streptococci, pneumococci, and staphylococci.
The latex-free injection which is expected to be launched in early 2012 will be available in three single-dose vial sizes.
Clindamycin features the company’s PreventIV MeasuresSM packaging and labeling designed to aid in the reduction of medication errors.